Advertisement
Screener

Loxo Oncology, Inc. Shareholders' Equity

Loxo Oncology, Inc. Shareholders' Equity

Loxo Oncology, Inc. had Shareholders' Equity of $379.21 million as of 2018-09-30, per its 10-Q filed 2018-11-08.

Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:StockholdersEquity · last filed 2018-11-08

  • 2018-09-30: Stockholders' Equity Attributable to Parent $379.21M.
  • 2018-06-30: Stockholders' Equity Attributable to Parent $392.12M.
  • 2018-03-31: Stockholders' Equity Attributable to Parent $384.42M.
  • 2017-12-31: Stockholders' Equity Attributable to Parent $378.21M.
Period endStockholders' Equity Attributable to Parent
2018-09-30$379.21M
10-Q · filed 2018-11-08
2018-06-30$392.12M
10-Q · filed 2018-08-09
2018-03-31$384.42M
10-Q · filed 2018-05-08
2017-12-31$378.21M
10-Q · filed 2018-11-08
2017-09-30$394.04M
10-Q · filed 2017-11-02
2017-06-30$461.25M
10-Q · filed 2017-08-08
2017-03-31$238.96M
10-Q · filed 2017-05-09
2016-12-31$130.17M
10-K · filed 2018-03-01
2016-09-30$154.81M
10-Q · filed 2016-11-02
2016-06-30$169.43M
10-Q · filed 2016-08-03
2016-03-31$145.15M
10-Q · filed 2016-05-04
2015-12-31$154.60M
10-K · filed 2018-03-01
2015-09-30$93.86M
10-Q · filed 2015-11-10
2015-06-30$101.47M
10-Q · filed 2015-08-05
2015-03-31$107.56M
10-Q · filed 2015-05-14
2014-12-31$112.67M
10-K · filed 2018-03-01
2014-09-30$119.34M
10-Q · filed 2014-11-14
2014-06-30-$16.37M
10-Q · filed 2014-10-07
2013-12-31-$10.23M
10-K · filed 2017-03-07